- Home
- ORIS vs KALA Comparison
ORIS vs KALA Comparison
Compare ORIS & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIS
- KALA
- Stock Information
- Founded
- ORIS 2014
- KALA 2009
- Country
- ORIS China
- KALA United States
- Employees
- ORIS N/A
- KALA N/A
- Industry
- ORIS Farming/Seeds/Milling
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- ORIS Consumer Staples
- KALA Health Care
- Exchange
- ORIS Nasdaq
- KALA Nasdaq
- Market Cap
- ORIS 5.3M
- KALA 5.1M
- IPO Year
- ORIS 2024
- KALA 2017
- Fundamental
- Price
- ORIS $0.13
- KALA $0.66
- Analyst Decision
- ORIS
- KALA Buy
- Analyst Count
- ORIS 0
- KALA 3
- Target Price
- ORIS N/A
- KALA $31.50
- AVG Volume (30 Days)
- ORIS 16.2M
- KALA 244.4K
- Earning Date
- ORIS 01-01-0001
- KALA 11-07-2025
- Dividend Yield
- ORIS N/A
- KALA N/A
- EPS Growth
- ORIS N/A
- KALA N/A
- EPS
- ORIS 0.17
- KALA N/A
- Revenue
- ORIS $15,014,000.00
- KALA N/A
- Revenue This Year
- ORIS N/A
- KALA N/A
- Revenue Next Year
- ORIS N/A
- KALA N/A
- P/E Ratio
- ORIS $0.71
- KALA N/A
- Revenue Growth
- ORIS N/A
- KALA N/A
- 52 Week Low
- ORIS $0.08
- KALA $0.64
- 52 Week High
- ORIS $56.01
- KALA $20.60
- Technical
- Relative Strength Index (RSI)
- ORIS 43.81
- KALA 27.23
- Support Level
- ORIS $0.11
- KALA $0.64
- Resistance Level
- ORIS $0.16
- KALA $0.73
- Average True Range (ATR)
- ORIS 0.02
- KALA 0.06
- MACD
- ORIS -0.00
- KALA 0.32
- Stochastic Oscillator
- ORIS 14.02
- KALA 31.24
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.